Delivery Order SPE2DB24D1205-SPE2DB25FCZTQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Advair HFA 115-21 microgram inhalers in 12-gram quantities. The contract was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order with a ceiling value of $1,650.58. The ultimate completion date is set for July 22, 2025, with the place...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a $10,402.76 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Advair HFA 115-21 microgram inhaler 12-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,068.76 to AmerisourceBergen Drug Corp for Advair HFA 45-21 microgram inhalers (12 grams) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a $14,025.54 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm). This is a firm fixed price delivery order with no set-aside designation, issued as a competitively awarded contract. The order is scheduled for ultimate completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $2,416.18 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award through open procurement. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gm) with a ceiling value of $1,987.83. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZTQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Advair HFA 115-21 mcg inhalers (12 gm) with a ceiling value of $9,527.48. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders. This award reflects the company's ongoing role in supporting military and federal healthcare supply chains through the DLA's pharmaceutical prime vendor program, which is designed to ensure timely and cost-effective access to essential medications and medical supplies for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 8/20/25 |